Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-25

Clinical Trial Update: Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ginger extract for motion sickness has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ginger extract (Zingiber officinale extract)

Snippet

Sponsor: Fundação Educacional Serra dos Órgãos | Conditions: Motion Sickness | Phase 4 | Status: COMPLETED